Company Filing History:
Years Active: 2024
Title: The Innovations of Christophe Lamarque
Introduction
Christophe Lamarque is an accomplished inventor based in Princeton, NJ (US). He has made significant contributions to the field of medical science, particularly in the area of glucose uptake inhibitors. His work focuses on developing compounds that can modulate glucose uptake activity, which has important implications for treating various diseases.
Latest Patents
Lamarque holds a patent for his invention related to glucose uptake inhibitors. This invention provides compounds that modulate glucose uptake activity and cellular transport of glucose, specifically targeting GLUTS3, while also including GLUT1-14 (SLC2A1-SLC2A14). The compounds he has developed are useful for treating diseases such as cancer, autoimmune diseases, inflammation, infectious diseases, and metabolic diseases. He has 1 patent to his name.
Career Highlights
Christophe Lamarque is currently employed at Kadmon Corporation, LLC, where he continues to innovate and contribute to the field of medical research. His work at Kadmon has allowed him to explore new avenues in the treatment of diseases related to glucose metabolism.
Collaborations
Lamarque has collaborated with notable colleagues, including Kevin G Liu and Kellen L Olszewski. These collaborations have further enhanced his research and development efforts in the field.
Conclusion
Christophe Lamarque's contributions to the field of glucose uptake inhibitors highlight his innovative spirit and dedication to improving medical treatments. His work has the potential to make a significant impact on the treatment of various diseases.